IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals |
|
Adaptive subsets limit the anti-tumoral NK-cell activity in hepatocellular carcinoma |
|
Auswirkungen der Hypoxie auf virusspezifische CD8+T-Zellen |
|
Breast cancer stem cell–derived tumors escape from [gamma][delta] T-cell immunosurveillance in vivo by modulating [gamma][delta] T-cell ligands |
|
CD8+ T cell responses during HCV infection and HCC |
|
Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease |
|
COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation |
|
Decreased level of serum NT-proCNP associates with disease severity in COVID-19 |
|
Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominids |
|
Early SARS-CoV-2 infection: platelet-neutrophil complexes and platelet function |
|
Editorial: Memory T cells in chronic infections and tumors |
|
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+T cells |
|
Follicular T helper cell signatures in primary biliary cholangitis and primary sclerosing cholangitis |
|
Hepatitis B vaccine and NK cells: a new player in memory |
|
Hepatitis C virus and human cytomegalovirus - natural killer cell subsets in persistent viral infections |
|
Hepatitis D infection induces IFN-β-mediated NK cell activation and TRAIL-dependent cytotoxicity = Hepatitis D infection induces IFN-[Beta]-mediated NK cell activation and TRAIL-dependent cytotoxicity |
|
Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy |
|
Immunopathology caused by impaired CD8+ T‐cell responses |
|
Impact of dietary vitamin D on immunoregulation and disease pathology in lupus-prone NZB/W F1 mice |
|
Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma |
|
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses |
|
Intestinal B-cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling |
|
Killer cell lectin-like receptor G1 and its ligand E-cadherin functional and structural analyses and impact on a novel memory T-cell population in salivary glands |
|
Mechanisms of CD8+ T cell failure in chronic hepatitis E virus infection |
|
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics |
|
Multimodal profiling reveals site-specific adaptation and tissue residency hallmarks of γδ T cells across organs in mice = Multimodal profiling reveals site-specific adaptation and tissue residency hallmarks of [gamma][delta] T cells across organs in mice |
|
Mutational escape from cellular immunity in viral hepatitis: variations on a theme |
|
Mutations in hepatitis D virus allow it to escape detection by CD8+ T cells and evolve at the population level |
|
Neoantigens as potential vaccines in hepatocellular carcinoma |
|
A novel null‐allele, HLA‐B*35:574N, containing a mutation in the start‐codon |
|
Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment |
|
Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load |
|
Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination |
|
Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine |
|
Role of immunomodulators in functional cure strategies for HBV |
|
SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals |
|
SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants |
|
TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation |
|
Th1-biased hepatitis C virus-specific follicular T helper-like cells effectively support B cells after antiviral therapy |
|
TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection |
|
Unique and common features of innate-like human V[delta]2+ [gamma] [delta] T cells and mucosal-associated invariant T cells |
|
Ustekinumab inhibits T follicular helper cell differentiation in patients with Crohn’s disease |
|